Structure-activity relationships in luteinizing hormone-releasing hormone

Area of Science:

• Endocrinology
• Medicinal Chemistry
• Peptide Synthesis

Background:

• Luteinizing hormone-releasing hormone (LH-RH) is a decapeptide hormone crucial for reproductive functions.
• Modifications of LH-RH can lead to analogs with altered biological activities.
• Solid-phase synthesis enables the creation of complex peptide structures.

Purpose of the Study:

• To synthesize and characterize novel LH-RH analogs with substitutions at positions 1, 3, and 8.
• To evaluate the in vivo LH-RH activity of these synthetic analogs.
• To assess the potential of a specific analog in modulating luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release.

Main Methods:

• Solid-phase peptide synthesis was employed to create three LH-RH analogs: [pyro-L-alpha-(1-aminoadipic)]-LH-RH, [3-(2-naphthyl)-L-Ala3]-LH-RH, and [delta-N-i-Pr-L-Orn8]-LH-RH.
• In vivo LH-RH activity was assessed in ovariectomized rats treated with estrogen and progesterone.
• The effect on LH and FSH release was evaluated in immature male rats following subcutaneous injection.

Main Results:

• The synthesized analogs exhibited varying LH-RH activities: 12.5%, 51.8%, and 3.7% compared to native LH-RH.
• [3-(2-naphthyl)-Ala3]-LH-RH demonstrated a 1.2-fold increase in LH release and a 0.8-fold change in FSH release compared to synthetic LH-RH in immature male rats.

Conclusions:

• Nonprotein amino acid substitutions can significantly modulate the biological activity of LH-RH analogs.
• [3-(2-naphthyl)-Ala3]-LH-RH shows potential for differential regulation of LH and FSH release.
• Further investigation into these modified LH-RH analogs may yield new therapeutic agents for reproductive disorders.